Skip to main content

BRS-X(ECS) — Endocannabinoid System

BRS-X(ECS-PM2) - Omega-3-Derived Endocannabinoidome Signalling​

1. Definition​

Production of omega-3-derived ethanolamides and related signalling molecules including DHEA and EPEA from EPA and DHA availability.

2. Target Functional Outcome / Phenome​

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Cognitive Clarity — modulates
  • Confidence: low-medium
  • Evidence Level: mechanistic
  • Rationale: Omega-3-derived ethanolamides may support neuroprotective and neurogenesis-related signalling context relevant to cognitive clarity without CB1-centric framing.
  • Key References:
Stress Resilience — modulates
Emotional Regulation — modulates
  • Confidence: low
  • Evidence Level: mechanistic
  • Rationale: Omega-3 endocannabinoidome signalling may indirectly modulate affective context through inflammatory and neuromodulatory interfaces; direct ADHD evidence remains limited.
  • Key References:

3. Intervention Breakdown​

Food-State Dominant

4. Functional Role​

↑ omega-3-derived ethanolamide signalling; ↑ anti-inflammatory endocannabinoidome context; ↑ neuroprotective and neurogenesis-supportive lipid mediator pools; ↓ low EPA/DHA substrate limitation

5. Mechanistic Basis​

Summary​

EPA and DHA availability supports production of omega-3-derived ethanolamides including DHEA and EPEA within BRS-X(ECS-FM1), linking dietary omega-3 biology to endocannabinoidome signalling rather than CB1 receptor activation [1][2][3].

Omega-3 ethanolamide signalling

(DHEA and EPEA production)​

Emerging evidence supports omega-3 fatty acid-derived endocannabinoids and ethanolamide derivatives as diet-actionable signalling molecules with neurobiological relevance → Watson et al. (2019) [1]

(Omega-3 and endocannabinoid system coupling)​

Omega-3 fatty acids intersect mechanistically with endocannabinoid system tone and cardiometabolic-inflammatory context → Saleh-Ghadimi et al. (2020) [2]

(DHEA immunomodulatory signalling)​

DHA-derived docosahexaenoylethanolamine (DHEA) shows anti-inflammatory N-acyl ethanolamide activity in macrophage models, supporting a diet-linked omega-3 endocannabinoidome mechanism → Meijerink et al. (2011) [3]

(Boundaries of the mechanism)​

Classical NAPE → NAE biosynthesis from phospholipids belongs to BRS-X(ECS-PM1). Membrane DHA incorporation belongs to BRS1-FM4-PM5.

(Integration within BRS-X(ECS))​

This PM operationalises the omega-3 arm of BRS-X(ECS-FM1), intersecting BRS-X(ECS-KC1) phospholipid substrate context.

6. Connected BRS-X(ECS) Mechanisms​

6.1 Overarching Functional Mechanism​

6.2 Connected Primary Mechanisms​

7. Connected Mechanisms​

8. Dietary Levers​

8.1 Direct Dietary Levers​

  • Oily fish ← salmon, sardines, mackerel
  • Algal and marine omega-3 sources ← fish, roe
  • Walnuts and ALA-rich whole foods ← walnuts, flaxseed (conversion context)

8.2 Cofactors and Supporting Inputs​

  • EPA
  • DHA

8.3 KCs (Key Constraints)​

9. Lifestyle Levers​

Lifestyle
  • Regular oily-fish or equivalent omega-3 patterns may support ethanolamide substrate availability.
  • Chronic ultra-processed low-omega-3 diets may limit DHEA/EPEA-related endocannabinoidome signalling context.

10. References​

  1. Watson et al. (2019)
  2. Saleh-Ghadimi et al. (2020)
  3. Meijerink et al. (2011)